• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病运动障碍性构音障碍的言语和语言治疗:系统评价和荟萃分析。

Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis.

机构信息

Department of Physiotherapy, Faculty of Health Sciences, University of Granada, Granada, Spain.

出版信息

Clin Rehabil. 2021 May;35(5):639-655. doi: 10.1177/0269215520976267. Epub 2020 Nov 24.

DOI:10.1177/0269215520976267
PMID:33233932
Abstract

OBJECTIVE

To assess the effect of speech and language therapy (SLT) on Hypokinetic dysarthria (HD) in Parkinson's disease.

DESIGN

Systematic review and meta-analysis of randomized controlled trials.

METHODS

We performed a literature search of randomized controlled trials using PubMed, Web of Science, Science Direct and Cochrane database (last search October 2020). Quality assessment and risk of bias were assessed using the Downs and Black scale and the Cochrane tool. The data were pooled and a meta-analysis was completed for sound pressure levels, perceptual intelligibility and inflection of voice fundamental frequency.

RESULTS

We selected 15 high to moderate quality studies, which included 619 patients with Parkinson's disease. After pooling the data, 7 studies, which compared different speech language therapies to no treatment, control groups and 3 of their variables, (sound pressure level, semitone standard deviation and perceptual intelligibility) were included in the analysis.Results showed significant differences in favor of SLT for sound pressure level sustained phonation tasks (standard mean difference = 1.79; 95% confidence interval = 0.86, 2.72; ⩽ 0.0001). Significant results were also observed for sound pressure level and semitone standard deviation in reading tasks (standard mean difference = 1.32; 95% confidence interval = 1.03, 1.61; ⩽ 0.0001). Additionally, sound pressure levels in monologue tasks showed similar results when SLT was compared to other treatments (standard mean difference = 0.87; 95% confidence interval = 0.46, 1.28; ⩽ 0.0001).

CONCLUSION

This meta-analysis suggests a beneficial effect of SLT for reducing Hypokinetic Dysarthria in Parkinson's disease, improving perceptual intelligibility, sound pressure level and semitone standard deviation.

摘要

目的

评估言语语言治疗(SLT)对帕金森病运动障碍性构音障碍(HD)的疗效。

设计

随机对照试验的系统评价和荟萃分析。

方法

我们使用 PubMed、Web of Science、Science Direct 和 Cochrane 数据库(最后一次搜索时间为 2020 年 10 月)进行了随机对照试验的文献检索。使用 Downs 和 Black 量表以及 Cochrane 工具评估质量和偏倚风险。对数据进行合并,并对声压级、感知可懂度和基频语调进行荟萃分析。

结果

我们选择了 15 项高质量到中等质量的研究,其中包括 619 名帕金森病患者。对数据进行合并后,纳入了 7 项研究,这些研究比较了不同的言语语言治疗与无治疗、对照组以及其中 3 个变量(声压级、半音标准差和感知可懂度)的差异。结果显示,在持续发音任务的声压级(标准均数差 = 1.79;95%置信区间 = 0.86,2.72; ⩽ 0.0001)方面,SLT 有显著优势。在阅读任务的声压级和半音标准差方面也观察到了显著结果(标准均数差 = 1.32;95%置信区间 = 1.03,1.61; ⩽ 0.0001)。此外,在与其他治疗方法比较时,SLT 对独白任务的声压级也有类似的效果(标准均数差 = 0.87;95%置信区间 = 0.46,1.28; ⩽ 0.0001)。

结论

这项荟萃分析表明,SLT 对降低帕金森病运动障碍性构音障碍、提高感知可懂度、声压级和半音标准差有有益作用。

相似文献

1
Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis.帕金森病运动障碍性构音障碍的言语和语言治疗:系统评价和荟萃分析。
Clin Rehabil. 2021 May;35(5):639-655. doi: 10.1177/0269215520976267. Epub 2020 Nov 24.
2
Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.帕金森病言语问题的言语和语言治疗技术比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD002814. doi: 10.1002/14651858.CD002814.pub2.
3
A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.帕金森病构音障碍的言语和语言治疗技术比较
Cochrane Database Syst Rev. 2001(2):CD002814. doi: 10.1002/14651858.CD002814.
4
Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.在线治疗帕金森病患者的言语和嗓音障碍:一项随机对照非劣效性试验。
Int J Lang Commun Disord. 2011 Jan-Feb;46(1):1-16. doi: 10.3109/13682822.2010.484848.
5
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.一项多中心、随机对照试验,旨在比较李·西尔弗曼嗓音治疗与标准国民保健制度语音和语言治疗与对照组在帕金森病中的临床和成本效益:一项随机对照试验的研究方案。
Trials. 2020 May 27;21(1):436. doi: 10.1186/s13063-020-04354-7.
6
Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.言语和语言治疗与安慰剂或不干预对帕金森病言语问题的疗效比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD002812. doi: 10.1002/14651858.CD002812.pub2.
7
Speech and Language Therapy for Voice Problems in Parkinson's Disease: A Meta-Analysis.帕金森病语音问题的言语和语言治疗:一项荟萃分析。
J Neuropsychiatry Clin Neurosci. 2020 Fall;32(4):344-351. doi: 10.1176/appi.neuropsych.19020044. Epub 2020 May 6.
8
Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.李·西尔弗曼语音治疗帕金森病患者构音障碍:系统评价和荟萃分析。
Eur J Neurol. 2020 Oct;27(10):1957-1970. doi: 10.1111/ene.14399. Epub 2020 Aug 12.
9
Speech and language therapy for dysarthria in Parkinson's disease.帕金森病构音障碍的言语和语言治疗
Cochrane Database Syst Rev. 2001(2):CD002812. doi: 10.1002/14651858.CD002812.
10
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.李·西尔弗曼语音治疗与英国国民保健制度(NHS)言语和语言治疗对照治疗帕金森病(PD COMM)患者构音障碍的实用性、基于英国、多中心、三臂、平行组、非盲、随机对照试验。
BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341.

引用本文的文献

1
An Interdisciplinary Approach to Assistive Technology for Parkinson's Disease Dementia.一种针对帕金森病痴呆症辅助技术的跨学科方法。
Clin Interv Aging. 2025 Aug 15;20:1253-1265. doi: 10.2147/CIA.S516786. eCollection 2025.
2
Effect of Treatment of Hypokinetic Dysarthria in Parkinson's Disease with Speech and Language Therapy: A Meta-Analysis.言语和语言治疗对帕金森病运动减少型构音障碍的治疗效果:一项荟萃分析
Iran J Public Health. 2025 Jun;54(6):1118-1131. doi: 10.18502/ijph.v54i6.18890.
3
Speech Characteristics Across Motor Subtypes of Parkinson's Disease.
帕金森病运动亚型的言语特征
Int J Lang Commun Disord. 2025 Jul-Aug;60(4):e70081. doi: 10.1111/1460-6984.70081.
4
Prevalence and Treatment of Dysphonia in Parkinson's Disease: A Cross-Sectional National Database Study.帕金森病中发声障碍的患病率及治疗:一项全国性横断面数据库研究
Laryngoscope Investig Otolaryngol. 2025 May 14;10(3):e70149. doi: 10.1002/lio2.70149. eCollection 2025 Jun.
5
Parkinson's Disease, Speech and Neurosurgery.帕金森病、言语与神经外科
Brain Behav. 2025 May;15(5):e70101. doi: 10.1002/brb3.70101.
6
Intensive Speech Therapy for Hypokinetic Dysarthria in Parkinson's Disease: Targeting the Five Subsystems of Speech Production with Clinical and Instrumental Evaluation.帕金森病运动减少型构音障碍的强化言语治疗:通过临床和仪器评估针对言语产生的五个子系统
NeuroSci. 2025 Jan 16;6(1):7. doi: 10.3390/neurosci6010007.
7
Unveiling early signs of Parkinson's disease via a longitudinal analysis of celebrity speech recordings.通过对名人语音记录的纵向分析揭示帕金森病的早期迹象。
NPJ Parkinsons Dis. 2024 Oct 27;10(1):207. doi: 10.1038/s41531-024-00817-9.
8
Stemming the Tide: The Proactive Role of Allied Health Therapy in Parkinson's Disease.遏制潮流:联合健康治疗在帕金森病中的积极作用。
J Parkinsons Dis. 2024;14(s1):S7-S19. doi: 10.3233/JPD-230267.
9
[Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment].[帕金森病的多学科综合治疗:个体化治疗的基石]
Nervenarzt. 2024 Aug;95(8):704-713. doi: 10.1007/s00115-024-01666-w. Epub 2024 May 16.
10
Adherence to Non-Pharmacological Interventions in Parkinson's Disease: A Rapid Evidence Assessment of the Literature.帕金森病中非药物干预措施的依从性:文献快速证据评估。
J Parkinsons Dis. 2024;14(s1):S35-S52. doi: 10.3233/JPD-230266.